Refractory and Relapsed Primary CNS Lymphoma
1 clinical trials · Condition
◉ Watch Refractory and Relapsed Primary CNS Lymphoma
| Record | Firm | Date |
|---|---|---|
| Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma (NCT05021770) | Huiqiang Huang | 2021-12-01 |
Track Refractory and Relapsed Primary CNS Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.